Pursuant to Rule 424(b)(4)
Registration No. 333-248551
Prospectus
Bluescape Opportunities Acquisition Corp.
$575,000,000
57,500,000 Units
Bluescape Opportunities Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We will not be limited to a particular industry or geographic region in our identification and acquisition of a target company.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to 8,625,000 additional units to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination, subject to the limitations as described herein. If we have not consummated an initial business combination within 24 months from the closing of this offering, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described herein.
Our sponsor, Bluescape Sponsor LLC, and an investment fund managed by Zimmer Partners, LP (the “Zimmer Entity”) have agreed, severally and not jointly, to purchase an aggregate of 13,500,000 warrants (or 15,225,000 warrants if the underwriters’ over-allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, subject to adjustment, at a price of $1.00 per warrant, in a private placement to occur concurrently with the closing of this offering. Our initial shareholders currently own 16,531,250 Class B ordinary shares, up to 2,156,250 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described herein. Prior to our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the appointment of directors.
Prior to the consummation of this offering, we have entered into forward purchase agreements with each of our sponsor and the Zimmer Entity, pursuant to which our sponsor and the Zimmer Entity have committed to purchase in aggregate, up to 30,000,000 units, at a purchase price of $10.00 per unit, with each unit to consist of one Class A ordinary share and one-half of one warrant to purchase one Class A ordinary share at $11.50, in private placements to occur concurrently, and only in connection with, the closing of our initial business combination. The obligations of our sponsor and the Zimmer Entity to purchase the forward purchase units are subject to the approval, prior to our entering into a definitive agreement for our initial business combination, of their respective investment committees. The warrants to be issued as part of the forward purchase agreements will be identical to the private placement warrants. The obligations of our sponsor and the Zimmer Entity under the forward purchase agreements do not depend on whether any Class A ordinary shares are redeemed by our public shareholders.
Currently, there is no public market for our securities. We have been approved to list our units on the New York Stock Exchange, or the NYSE, under the symbol “BOAC.U.” We expect that the Class A ordinary shares and warrants comprising the units will begin separate trading on the NYSE under the symbols “BOAC” and “BOACWS,” respectively, on the 52nd day following the date of this prospectus unless the underwriters permit earlier separate trading and we have satisfied certain conditions.
We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 31 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | Per Unit | | | Total | |
Public offering price | | | $10.00 | | | $575,000,000 | |
Underwriting discounts and commissions(1) | | | $0.55 | | | $31,625,000 | |
Proceeds, before expenses, to us | | | $9.45 | | | $543,375,000 | |
(1)
Includes $0.35 per unit, or $20,125,000 (or up to $23,143,750 if the underwriters’ option to purchase additional units is exercised in full) in the aggregate, payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described herein. The deferred commissions will be released to the underwriters only on completion of an initial business combination, in an amount equal to $0.35 multiplied by the number of shares of Class A ordinary shares sold as part of the units in this offering, as described in this prospectus. Does not include certain fees and expenses payable to the underwriters in connection with this offering. See “Underwriting” for a description of compensation and other items of value payable to the underwriters.
Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $575,000,000, or $661,250,000 if the underwriters’ option to purchase additional units is exercised in full ($10.00 per unit in either case), will be deposited into a U.S.-based trust account at Citibank, N.A., with Continental Stock Transfer & Trust Company acting as trustee.
The underwriters are offering the units for sale on a firm commitment basis. The underwriters expect to deliver the units to the purchasers on or about October 30,2020.
Book-Running Managers
The date of this prospectus is October 27, 2020